Psych · foundations — psychiatric genetics and epigenetics
Psychiatric genetics and epigenetics
Also known as Psychiatric genomics · Heritability mental disorders · GWAS schizophrenia depression · Polygenic risk score psychiatry · Copy number variants psychosis · 22q11.2 deletion syndrome psychiatry · Epigenetics mental illness · Genetic counselling psychiatry · Gene environment interaction psychiatry
Exam-exhaustive psychiatric genetics and epigenetics for FRANZCP and MRCPsych: heritability and twin/adoption designs; liability-threshold and ACE models; GWAS architecture of schizophrenia and depression; CNVs including 22q11.2DS; polygenic risk scores and clinical limits; epigenetics as GxE mechanism; genetic counselling basics and ethics. FRANZCP-primary, globally tagged.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Treating heritability as the percent of an individual's illness that is genetic — it is a population variance statistic
- Promising a single gene for schizophrenia or routine clinical PRS diagnosis of common mental disorders
- Applying European-ancestry polygenic scores uncritically to other ancestries
- Ordering genome-wide testing without counselling infrastructure, consent for secondary findings, or clinical genetics support
- Missing syndromic clues (congenital heart disease, hypocalcaemia, dysmorphology, ID) that should trigger 22q11/CNV evaluation
- Genetic essentialism that fuels stigma, therapeutic nihilism, or reproductive coercion
Meet the paper
In July 2014 the Schizophrenia Working Group of the Psychiatric Genomics Consortium published a single paper in Nature that is the line where psychiatric genetics grew up: 108 genome-wide significant loci for schizophrenia, across roughly 37,000 cases and 113,000 controls, with biological signals pointing at synaptic genes and the immune or MHC region.[5]
What changed was not the clinic — it was the exam question. Before 2014, registrars could answer "schizophrenia is heritable but we have not found the genes." After 2014 the honest answer became "highly polygenic, many loci of small effect, no single causative gene, and a polygenic score that is a research tool rather than a clinic test."[5][17]
This topic teaches that architecture: what twin studies and GWAS actually show, what 22q11.2 deletion means at the bedside, and where genomics changes a formulation without changing first-line treatment.[1][13]
References17ShowHide
- [1]Sullivan PF, Kendler KS, Neale MC Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies Arch Gen Psychiatry, 2003.PMID 14662550
- [2]Hilker R, Helenius D, Fagerlund B, et al. Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register Biol Psychiatry, 2018.PMID 28987712
- [3]Sullivan PF, Neale MC, Kendler KS Genetic epidemiology of major depression: review and meta-analysis Am J Psychiatry, 2000.PMID 11007705
- [4]McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression Arch Gen Psychiatry, 2003.PMID 12742871
- [5]Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature, 2014.PMID 25056061
- [6]Trubetskoy V, Pardiñas AF, Qi T, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia Nature, 2022.PMID 35396580
- [7]Wray NR, Ripke S, Mattheisen M, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression Nat Genet, 2018.PMID 29700475
- [8]International Schizophrenia Consortium; Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature, 2009.PMID 19571811
- [9]Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis Lancet, 2013.PMID 23453885
- [10]Cross-Disorder Group of the Psychiatric Genomics Consortium Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders Cell, 2019.PMID 31835028
- [11]Malhotra D, Sebat J CNVs: harbingers of a rare variant revolution in psychiatric genetics Cell, 2012.PMID 22424231
- [12]Marshall CR, Howrigan DP, Merico D, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects Nat Genet, 2017.PMID 27869829
- [13]Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome J Pediatr, 2011.PMID 21570089
- [14]McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome Nat Rev Dis Primers, 2015.PMID 27189754
- [15]Singh T, Poterba T, Curtis D, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia Nature, 2022.PMID 35396579
- [16]Weaver ICG, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior Nat Neurosci, 2004.PMID 15220929
- [17]Lewis CM, Vassos E Polygenic risk scores: from research tools to clinical instruments Genome Med, 2020.PMID 32423490